Announcement of Stayed Hearing: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I, 48515 [2024-12504]

Download as PDF 48515 Proposed Rules Federal Register Vol. 89, No. 111 Friday, June 7, 2024 This section of the FEDERAL REGISTER contains notices to the public of the proposed issuance of rules and regulations. The purpose of these notices is to give interested persons an opportunity to participate in the rule making prior to the adoption of the final rules. DEPARTMENT OF JUSTICE Drug Enforcement Administration 21 CFR Part 1308 [Docket No. DEA–1156] Announcement of Stayed Hearing: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4iodoamphetamine (DOI) and 2,5dimethoxy-4-chloroamphetamine (DOC) in Schedule I Drug Enforcement Administration, Department of Justice. ACTION: Notification of stay of hearing on proposed rulemaking. AGENCY: This is a notification that the Drug Enforcement Administration has stayed the June 10, 2024 hearing on the proposed placement of two phenethylamine hallucinogens, as identified in the proposed rule, in schedule I of the Controlled Substances Act. DATES: The hearing will not be taking place on June 10, 2024. ADDRESSES: Office of the Administrative Law Judges, 8701 Morrissette Drive, Springfield, Virginia 22152. FOR FURTHER INFORMATION CONTACT: Hearing Clerk, Debralynn Rosario, Office of the Administrative Law Judges, 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362– 7035. SUPPLEMENTARY INFORMATION: ddrumheller on DSK120RN23PROD with PROPOSALS1 SUMMARY: Background On December 13, 2023, the Drug Enforcement Administration (DEA) published a Notice of Proposed Rulemaking (NPRM) in the Federal Register (88 FR 86278) to place two phenethylamine hallucinogen substances in schedule I of the Controlled Substances Act (CSA) (21 U.S.C. 801, et seq.). Specifically, in this NPRM, DEA proposed to schedule the following two controlled substances in schedule I of the CSA, including their salts, isomers, and salts of isomers VerDate Sep<11>2014 16:36 Jun 06, 2024 Jkt 262001 whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: • 2,5-dimethoxy-4-iodoamphetamine (DOI), and • 2,5-dimethoxy-4chloroamphetamine (DOC). On April 9, 2024, DEA published a Notice of Hearing on Proposed Rulemaking (Notice of Hearing) in the FR (89 FR 24750) stating that a hearing would commence on June 10, 2024. Subsequently, a collateral matter was filed in a U.S. District Court and the DEA Administrative Law Judge stayed the administrative hearing proceedings pending a decision from the U.S. District Court. As the matter before DEA is currently stayed, no hearing will commence on June 10, 2024. ACTION: Signing Authority This document of the Drug Enforcement Administration was signed on June 3, 2024, by Administrator Anne Milgram. That document with the original signature and date is maintained by DEA. For administrative purposes only, and in compliance with requirements of the Office of the Federal Register, the undersigned DEA Federal Register Liaison Officer has been authorized to sign and submit the document in electronic format for publication, as an official document of DEA. This administrative process in no way alters the legal effect of this document upon publication in the Federal Register. You may submit comments using the Federal Decision-Making Portal at https://www.regulations.gov. See the ‘‘Public Participation and Request for Comments’’ portion of the SUPPLEMENTAL INFORMATION section for further instructions on submitting comments. Heather Achbach, Federal Register Liaison Officer, Drug Enforcement Administration. [FR Doc. 2024–12504 Filed 6–6–24; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF HOMELAND SECURITY Coast Guard 33 CFR Part 151 [Docket No. USCG–2024–0046] Recordkeeping and Reporting Requirements To Document Environmental Compliance on Certain Commercial Vessels Coast Guard, Department of Homeland Security (DHS). AGENCY: PO 00000 Frm 00001 Fmt 4702 Sfmt 4702 Request for information. The Coast Guard seeks information about the recordkeeping and reporting procedures required under the Coast Guard ballast water regulations issued in 2012 and 2015 and the monitoring, recordkeeping, and reporting required under the U.S. Environmental Protection Agency (EPA) 2013 Vessel General Permit (VGP). The Coast Guard plans to use this information to evaluate new and updated solutions that inform datadriven policymaking, reduce the reporting and record-keeping burden on industry, and confirm environmental compliance. SUMMARY: Comments must be received by the Coast Guard on or before July 22, 2024. DATES: ADDRESSES: For information about this document, email or phone Joseph Adamson, U.S. Coast Guard; email: CG-OES@uscg.mil, telephone: 206–836–3831. SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: I. Public Participation and Comments We encourage you to submit comments or related material responding to this request for information. The Coast Guard views public participation as essential to understanding the recordkeeping and reporting requirements for documenting environmental compliance. We consider all submissions and may adjust agency policy based on your feedback. If you submit a comment, please include the docket number for this notice (USCG– 2024–0046), indicate the specific section of this document to which each comment applies, and provide a detailed description of the issues, the reasoning, and suggestion or recommendations for solutions. Methods for submitting comments. We encourage you to submit comments through the Federal Decision-Making Portal at www.regulations.gov. To do so, go to www.regulations.gov, type USCG– 2024–0046 in the search box and click E:\FR\FM\07JNP1.SGM 07JNP1

Agencies

[Federal Register Volume 89, Number 111 (Friday, June 7, 2024)]
[Proposed Rules]
[Page 48515]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12504]


========================================================================
Proposed Rules
                                                Federal Register
________________________________________________________________________

This section of the FEDERAL REGISTER contains notices to the public of 
the proposed issuance of rules and regulations. The purpose of these 
notices is to give interested persons an opportunity to participate in 
the rule making prior to the adoption of the final rules.

========================================================================


Federal Register / Vol. 89, No. 111 / Friday, June 7, 2024 / Proposed 
Rules

[[Page 48515]]



DEPARTMENT OF JUSTICE

Drug Enforcement Administration

21 CFR Part 1308

[Docket No. DEA-1156]


Announcement of Stayed Hearing: Schedules of Controlled 
Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-
dimethoxy-4-chloroamphetamine (DOC) in Schedule I

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Notification of stay of hearing on proposed rulemaking.

-----------------------------------------------------------------------

SUMMARY: This is a notification that the Drug Enforcement 
Administration has stayed the June 10, 2024 hearing on the proposed 
placement of two phenethylamine hallucinogens, as identified in the 
proposed rule, in schedule I of the Controlled Substances Act.

DATES: The hearing will not be taking place on June 10, 2024.

ADDRESSES: Office of the Administrative Law Judges, 8701 Morrissette 
Drive, Springfield, Virginia 22152.

FOR FURTHER INFORMATION CONTACT: Hearing Clerk, Debralynn Rosario, 
Office of the Administrative Law Judges, 8701 Morrissette Drive, 
Springfield, Virginia 22152; Telephone: (571) 362-7035.

SUPPLEMENTARY INFORMATION: 

Background

    On December 13, 2023, the Drug Enforcement Administration (DEA) 
published a Notice of Proposed Rulemaking (NPRM) in the Federal 
Register (88 FR 86278) to place two phenethylamine hallucinogen 
substances in schedule I of the Controlled Substances Act (CSA) (21 
U.S.C. 801, et seq.). Specifically, in this NPRM, DEA proposed to 
schedule the following two controlled substances in schedule I of the 
CSA, including their salts, isomers, and salts of isomers whenever the 
existence of such salts, isomers, and salts of isomers is possible 
within the specific chemical designation:
     2,5-dimethoxy-4-iodoamphetamine (DOI), and
     2,5-dimethoxy-4-chloroamphetamine (DOC).
    On April 9, 2024, DEA published a Notice of Hearing on Proposed 
Rulemaking (Notice of Hearing) in the FR (89 FR 24750) stating that a 
hearing would commence on June 10, 2024. Subsequently, a collateral 
matter was filed in a U.S. District Court and the DEA Administrative 
Law Judge stayed the administrative hearing proceedings pending a 
decision from the U.S. District Court. As the matter before DEA is 
currently stayed, no hearing will commence on June 10, 2024.

Signing Authority

    This document of the Drug Enforcement Administration was signed on 
June 3, 2024, by Administrator Anne Milgram. That document with the 
original signature and date is maintained by DEA. For administrative 
purposes only, and in compliance with requirements of the Office of the 
Federal Register, the undersigned DEA Federal Register Liaison Officer 
has been authorized to sign and submit the document in electronic 
format for publication, as an official document of DEA. This 
administrative process in no way alters the legal effect of this 
document upon publication in the Federal Register.

Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2024-12504 Filed 6-6-24; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.